• Abera Bioscience published a video of CEO Maria Alriksson's presentation at Aktiespararna's Life Science event on November 12, 2026.
• The presentation covers nasal spray vaccines, including a pneumococcal vaccine expected to reach its first Phase 1 participant within weeks.
• Watch the presentation: https://youtu.be/lZ6CJajeLzA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abera Bioscience AB published the original content used to generate this news brief via Cision (Ref. ID: 202611130609BITN____UKPR__SV_20261113-BIT-8874-0) on November 13, 2026, and is solely responsible for the information contained therein.